Skip to search.
 TSX Down 0.08% TSX Ventures Up 0.73%

OncoGenex Pharmaceuticals, Inc. (OGXI)

-NasdaqCM
0.71 Down 0.07(8.84%) Feb 5, 4:00PM EST
Prev Close:0.78
Open:0.79
Bid:0.62 x 3000
Ask:0.84 x 200
1y Target Est:2.15
Beta:1.76217
Earnings Date:Mar 24 - Mar 28 (Est.)
Day's Range:0.65 - 0.85
52wk Range:0.46 - 4.10
Volume:188,186
Avg Vol (3m):482,623
Market Cap:21.20M
P/E (ttm):N/A
EPS (ttm):-0.86
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OGXIDown 8.84%21.20M
CELGDown 3.96%76.91B
PFEUp 0.10%179.22B
BMYDown 0.12%99.48B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.31
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.91
Quarterly EPS Est (Dec-15) :-0.15
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback